Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20167 | 26114180 | J Gastrointestin Liver Dis | Non-invasive distinction of non-alcoholic fatty liver disease using urinary volatile organic compound analysis: early results. | 2015 | Details |
| A20168 | 26114083 | Curr Hepatol Rep | PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE. | 2015 | Details |
| A20169 | 26113985 | Open Heart | Capsaicin may have important potential for promoting vascular and metabolic health. | 2015 | Details |
| A20170 | 26113868 | Evid Based Complement Alternat Med | Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside. | 2015 | Details |
| A20171 | 26113297 | Am J Physiol Gastrointest Liver Physiol | Hepatic TLR4 signaling in obese NAFLD. | 2015 | Details |
| A20172 | 26112990 | Dig Dis Sci | Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact. | 2015 | Details |
| A20173 | 26112094 | Exp Mol Pathol | Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH). | 2015 | Details |
| A20174 | 26111358 | J Gastroenterol Hepatol | Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
| A20175 | 26108973 | Eur J Clin Invest | Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD. | 2015 | Details |
| A20176 | 26108664 | Am J Physiol Cell Physiol | Amelioration of nonalcoholic fatty liver disease by hepatic stimulator substance via preservation of carnitine palmitoyl transferase-1 activity. | 2015 | Details |
| A20177 | 26108652 | Indian J Gastroenterol | Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India. | 2015 | Details |
| A20179 | 26104139 | Histol Histopathol | Effect of diet/atorvastatin on atherosclerotic lesions associated to nonalcoholic fatty liver disease in chickens. | 2015 | Details |
| A20180 | 26103964 | BMC Gastroenterol | Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis. | 2015 | Details |
| A20181 | 26102213 | Nutrients | Hepatic Steatosis as a Marker of Metabolic Dysfunction. | 2015 | Details |
| A20182 | 26102086 | PLoS One | Elongation Factor 1A-1 Is a Mediator of Hepatocyte Lipotoxicity Partly through Its Canonical Function in Protein Synthesis. | 2015 | Details |
| A20183 | 26100857 | Nat Commun | A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism. | 2015 | Details |
| A20184 | 26100498 | J Hepatol | Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands. | 2015 | Details |
| A20186 | 26098879 | PLoS One | Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet. | 2015 | Details |
| A20187 | 26097608 | Int J Clin Exp Pathol | Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study. | 2015 | Details |
| A20188 | 26097546 | Int J Clin Exp Pathol | Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease. | 2015 | Details |
| A20190 | 26094890 | Cell Metab | Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling. | 2015 | Details |
| A20191 | 26090879 | Int J Sports Med | Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A20192 | 26090514 | ScientificWorldJournal | Histologic and Metabolic Derangement in High-Fat, High-Fructose, and Combination Diet Animal Models. | 2015 | Details |
| A20193 | 26090470 | Biomed Res Int | How Inflammation Impinges on NAFLD: A Role for Kupffer Cells. | 2015 | Details |
| A20194 | 26090468 | Biomed Res Int | Gut Microbiota: Association with NAFLD and Metabolic Disturbances. | 2015 | Details |
| A20195 | 26090419 | Biomed Res Int | Individual CLA Isomers, c9t11 and t10c12, Prevent Excess Liver Glycogen Storage and Inhibit Lipogenic Genes Expression Induced by High-Fructose Diet in Rats. | 2015 | Details |
| A20196 | 26090409 | Biomed Res Int | Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life. | 2015 | Details |
| A20197 | 26090093 | J Nutr Sci | Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies. | 2015 | Details |
| A20198 | 26088821 | Eur J Endocrinol | Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. | 2015 | Details |
| A20201 | 26087253 | PLoS One | Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age. | 2015 | Details |
| A20202 | 26086867 | Hum Gene Ther | Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. | 2015 | Details |
| A20203 | 26085908 | World J Hepatol | "Weighing the risk": Obesity and outcomes following liver transplantation. | 2015 | Details |
| A20204 | 26085906 | World J Hepatol | Non-alcoholic fatty liver disease in 2015. | 2015 | Details |
| A20205 | 26085904 | World J Hepatol | Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics. | 2015 | Details |
| A20206 | 26085300 | Sleep | Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea. | 2015 | Details |
| A20208 | 26083565 | PLoS One | Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20209 | 26083112 | Nutrients | Dietary Patterns Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Chinese Adults. | 2015 | Details |
| A20212 | 26080905 | Minerva Gastroenterol Dietol | The diagnosis and treatment of non-alcoholic fatty liver disease. | 2015 | Details |
| A20213 | 26080824 | Zhonghua Nei Ke Za Zhi | [Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model]. | 2015 | Details |
| A20216 | 26079073 | Z Gastroenterol | [First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology]. | 2015 | Details |
| A20218 | 26078820 | Oxid Med Cell Longev | Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20219 | 26078579 | World J Gastroenterol | Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis. | 2015 | Details |
| A20220 | 26078565 | World J Gastroenterol | Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. | 2015 | Details |
| A20221 | 26078558 | World J Gastroenterol | Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. | 2015 | Details |
| A20222 | 26078557 | World J Gastroenterol | What are the effects of proton pump inhibitors on the small intestine? | 2015 | Details |
| A20223 | 26078246 | Asia Pac J Clin Nutr | Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver disease in centrally obese but not in non-centrally obese patients with diabetes mellitus. | 2015 | Details |
| A20224 | 26078245 | Asia Pac J Clin Nutr | Nonalcoholic fatty liver disease prevalence in urban school-aged children and adolescents from the Yangtze River delta region: a cross-sectional study. | 2015 | Details |
| A20225 | 26078098 | J Physiol Biochem | FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice. | 2015 | Details |
| A20226 | 26077701 | Surg Obes Relat Dis | Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study. | 2015 | Details |
| A20227 | 26077675 | J Transl Med | Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. | 2015 | Details |
| A20228 | 26076903 | Annu Rev Nutr | Autophagy and Lipid Droplets in the Liver. | 2015 | Details |
| A20229 | 26076562 | Rom J Intern Med | Noninvasive Markers of Improvement of Liver Steatosis Achieved by Weight Reduction in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20230 | 26076555 | Rom J Intern Med | Chronic Kidney Disease--Chronic Liver Disease. An Immunologic Cross-talk. | 2015 | Details |
| A20231 | 26076224 | Can J Gastroenterol Hepatol | Nonmedicinal interventions in nonalcoholic fatty liver disease. | 2016 | Details |
| A20232 | 26074683 | World J Gastroenterol | Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease. | 2015 | Details |
| A20233 | 26073454 | Prog Lipid Res | Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. | 2015 | Details |
| A20234 | 26072069 | J Huazhong Univ Sci Technolog Med Sci | Review on the effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of non-alcoholic fatty liver disease. | 2015 | Details |
| A20235 | 26071793 | J Formos Med Assoc | Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients. | 2015 | Details |
| A20236 | 26071652 | PM R | Perception of Effort During Activity in Patients With Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20237 | 26070860 | Expert Rev Gastroenterol Hepatol | Physiology and pathophysiology of liver lipid metabolism. | 2015 | Details |
| A20238 | 26070409 | J Hepatol | Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. | 2015 | Details |
| A20239 | 26070222 | Am J Cardiol | Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis). | 2015 | Details |
| A20240 | 26069285 | Thorax | Altered gut-liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver. | 2015 | Details |
| A20241 | 26067771 | Hepatol Int | The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation. | 2015 | Details |
| A20242 | 26067236 | Elife | The genetic architecture of NAFLD among inbred strains of mice. | 2015 | Details |
| A20243 | 26066519 | Toxicology | A Northern contaminant mixture impairs pancreas function in obese and lean JCR rats and inhibits insulin secretion in MIN6 cells. | 2015 | Details |
| A20244 | 26066299 | Prostaglandins Leukot Essent Fatty Acids | Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation. | 2015 | Details |
| A20245 | 26064924 | Biomed Res Int | Nonalcoholic Steatohepatitis: A Search for Factual Animal Models. | 2015 | Details |
| A20246 | 26064858 | J Lifestyle Med | SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease. | 2014 | Details |
| A20247 | 26064382 | Int J Clin Exp Med | Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease. | 2015 | Details |
| A20248 | 26064294 | Int J Clin Exp Med | Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis. | 2015 | Details |
| A20249 | 26064107 | Int J Endocrinol | Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20251 | 26063386 | Expert Opin Biol Ther | Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives. | 2015 | Details |
| A20252 | 26062958 | Acta Derm Venereol | Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study. | 2016 | Details |
| A20253 | 26062079 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease and alteration in semen quality and reproductive hormones. | 2015 | Details |
| A20254 | 26062078 | Eur J Gastroenterol Hepatol | Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20255 | 26061453 | J Med Food | Maltitol Prevents the Progression of Fatty Liver Degeneration in Mice Fed High-Fat Diets. | 2015 | Details |
| A20256 | 26060704 | Iran J Public Health | Effect of Vitamin E and Metformin on Fatty Liver Disease in Obese Children- Randomized Clinical Trial. | 2014 | Details |
| A20257 | 26060181 | J Bioenerg Biomembr | Protective effects of dietary avocado oil on impaired electron transport chain function and exacerbated oxidative stress in liver mitochondria from diabetic rats. | 2015 | Details |
| A20258 | 26059365 | Nutrition | Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials. | 2014 | Details |
| A20259 | 26058864 | Am J Physiol Endocrinol Metab | Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. | 2015 | Details |
| A20260 | 26058518 | Antioxid Redox Signal | Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20261 | 26058319 | Liver Int | Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure. | 2015 | Details |
| A20262 | 26057287 | JAMA | Nonalcoholic fatty liver disease: a systematic review. | 2015 | Details |
| A20263 | 26056853 | Toxicol Mech Methods | Perfluorononanoic acid disturbed the metabolism of lipid in the liver of streptozotocin-induced diabetic rats. | 2015 | Details |
| A20264 | 26056025 | J Bone Miner Metab | Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20265 | 26055949 | J Hepatol | Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts. | 2015 | Details |
| A20266 | 26055348 | Nutr Res | Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats. | 2015 | Details |
| A20267 | 26055245 | Nat Rev Gastroenterol Hepatol | Inflammasome activation and function in liver disease. | 2015 | Details |
| A20268 | 26052390 | World J Hepatol | Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. | 2015 | Details |
| A20269 | 26052389 | World J Hepatol | Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal. | 2015 | Details |
| A20270 | 26052382 | World J Hepatol | Non-alcoholic fatty liver disease - the heart of the matter. | 2015 | Details |
| A20271 | 26052378 | World J Hepatol | Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. | 2015 | Details |
| A20272 | 26052375 | World J Hepatol | Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets. | 2015 | Details |
| A20273 | 26051274 | Biochem Biophys Res Commun | Succinate causes α-SMA production through GPR91 activation in hepatic stellate cells. | 2015 | Details |
| A20274 | 26051164 | Analyst | FT-IR imaging for quantitative determination of liver fat content in non-alcoholic fatty liver. | 2015 | Details |
| A20275 | 26049712 | Eur J Gastroenterol Hepatol | Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20276 | 26049707 | Eur J Gastroenterol Hepatol | Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test. | 2015 | Details |
| A20277 | 26049666 | Clin Investig Arterioscler | [Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis]. | 2015 | Details |
| A20278 | 26049073 | Semin Thromb Hemost | Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |